Erythromycin enhances CD4 + Foxp3 + regulatory T-cell responses in a rat model of smoke-induced lung inflammation

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Bai, Jing ^a   Qiu, Shi Lin ^a   Zhong, Xiao Ning ^a   Huang, Qiu Ping ^a   He, Zhi Yi ^a   Zhang, Jian Quan ^a   Liu, Guang Nan ^a   Li, Mei Hua ^a   Deng, Jing Min ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; ERYTHROMYCIN; INTERLEUKIN 35; INTERLEUKIN 8; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CIGARETTE SMOKING; CONTROLLED STUDY; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; ANIMAL; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; METABOLISM; SMOKING;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROMYCIN; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-8; PNEUMONIA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862297381     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/410232     Document Type: Article

References (37)

1. Pauwels R. A., Buist A. S., Calverley P. M. A., Jenkins C. R., Hurd S. S., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary American Journal of Respiratory and Critical Care Medicine 2001 163 5 1256 1276 (Pubitemid 32378468)
2. Rabe K. F., Hurd S., Anzueto A., Barnes P. J., Buist S. A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., Van Weel C., Zielinski J., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary American Journal of Respiratory and Critical Care Medicine 2007 176 6 532 555 (Pubitemid 47403272)
3. Agust A., MacNee W., Donaldson K., Cosio M., Hypothesis: does COPD have an autoimmune component? Thorax 2003 58 10 832 834 (Pubitemid 37239227)
4. Saetta M., Mariani M., Panina-Bordignon P., Turato G., Buonsanti C., Baraldo S., Bellettato C. M., Papi A., Corbetta L., Zuin R., Sinigaglia F., Fabbri L. M., Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2002 165 10 1404 1409 (Pubitemid 34522945)
5. Grumelli S., Corry D. B., Song L. Z., Song L., Green L., Huh J., Hacken J., Espada R., Bag R., Lewis D. E., Kheradmand F., An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema PLoS Medicine 2004 1, article e8
6. Cosio M. G., Guerassimov A., Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma American Journal of Respiratory and Critical Care Medicine 1999 160 5 S21 S25
7. Shevach E. M., Regulatory T cells in autoimmmunity Annual Review of Immunology 2000 18 423 449 (Pubitemid 30365387)
8. Dejaco C., Duftner C., Grubeck-Loebenstein B., Schirmer M., Imbalance of regulatory T cells in human autoimmune diseases Immunology 2006 117 3 289 300
9. Von Boehmer H., Mechanisms of suppression by suppressor T cells Nature Immunology 2005 6 4 338 344 (Pubitemid 41716770)
10. Collison L. W., Workman C. J., Kuo T. T., Boyd K., Wang Y., Vignali K. M., Cross R., Sehy D., Blumberg R. S., Vignali D. A. A., The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 2007 450 7169 566 569 (Pubitemid 350190247)
11. Ait-Oufella H., Salomon B. L., Potteaux S., Robertson A. K. L., Gourdy P., Zoll J., Merval R., Esposito B., Cohen J. L., Fisson S., Flavell R. A., Hansson G. K., Klatzmann D., Tedgui A., Mallat Z., Natural regulatory T cells control the development of atherosclerosis in mice Nature Medicine 2006 12 2 178 180 (Pubitemid 43214743)
12. Bluestone J. A., Tang Q., How do CD4 + CD25 + regulatory T cells control autoimmunity? Current Opinion in Immunology 2005 17 6 638 642 (Pubitemid 41506909)
13. Jiang H., Chess L., Regulation of immune responses by T cells The New England Journal of Medicine 2006 354 11 1116 1176
14. Mttnen M., Heikkinen J., Mustonen L., Isomki P., Luukkainen R., Lassila O., CD4 + CD25 + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis Clinical and Experimental Immunology 2005 140 2 360 367 (Pubitemid 40559165)
15. Lee S. H., Goswami S., Grudo A., Song L. Z., Bandi V., Goodnight-White S., Green L., Hacken-Bitar J., Huh J., Bakaeen F., Coxson H. O., Cogswell S., Storness-Bliss C., Corry D. B., Kheradmand F., Antielastin autoimmunity in tobacco smoking-induced emphysema Nature Medicine 2007 13 5 567 569 (Pubitemid 46828488)
16. McGarvey L. P., John M., Anderson J. A., Zvarich M., Wise R. A., Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee Thorax 2007 62 5 411 415 (Pubitemid 46698390)
17. Bourbeau J., Christodoulopoulos P., Maltais F., Yamauchi Y., Olivenstein R., Hamid Q., Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial Thorax 2007 62 11 938 943 (Pubitemid 350084490)
18. Harita S., Kuyama S., Okada T., Tanizaki Y., Effect of long-term and low-dose administration of erythromycin on proliferation of T lymphocytes stimulated with mitogens Journal of Chemotherapy 2008 20 5 604 608
19. Sun L., Liu J., Cui D., Li J., Yu Y., Lei M., Hu L., Anti-inflammatory function of withangulatin a by targeted inhibiting COX-2 expression via MAPK and NF- B pathways Journal of Cellular Biochemistry 2010 109 3 532 541
20. Shinkai M., Foster G. H., Rubin B. K., Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells American Journal of Physiology 2006 290 1 L75 L85
21. Suzuki T., Yamaya M., Sekizawa K., Hosoda M., Yamada N., Ishizuka S., Yoshino A., Yasuda H., Takahashi H., Nishimura H., Sasaki H., Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells American Journal of Respiratory and Critical Care Medicine 2002 165 8 1113 1118 (Pubitemid 34415820)
22. Nagai H., Shishido H., Yoneda R., Yamaguchi E., Tamura A., Kurashima A., Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis Respiration 1991 58 3-4 145 149
23. Keicho N., Kudoh S., Diffuse panbronchiolitis: role of macrolides in therapy American Journal of Respiratory Medicine 2002 1 2 119 131 (Pubitemid 37038930)
24. Azuma A., Kudoh S., Diffuse panbronchiolitis in East Asia Respirology 2006 11 3 249 261
25. King P., Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 2007 67 7 965 974 (Pubitemid 46744473)
26. Simpson J. L., Powell H., Boyle M. J., Scott R. J., Gibson P. G., Clarithromycin targets neutrophilic airway inflammation in refractory asthma American Journal of Respiratory and Critical Care Medicine 2008 177 2 148 155
27. Hahn D. L., Macrolide therapy in asthma: limited treatment, long-term improvement European Respiratory Journal 2009 33 5, article 1239
28. Zhong X. N., Bai J., Shi H. Z., Wu C., Liang G. R., Feng Z. B., An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema Zhonghua Jie He He Hu Xi Za Zhi 2003 26 12 750 755
29. Sorsa M., Einisto P., Husgafvel-Pursiainen K., Passive and active exposure to cigarette smoke in a smoking experiment Journal of Toxicology and Environmental Health 1985 16 3-4 523 534 (Pubitemid 16153222)
30. Thurlbeck W. M., The internal surface area of nonemphysematous lungs American Review of Respiratory Disease 1967 95 5 765 773
31. Seemungal T. A. R., Wilkinson T. M. A., Hurst J. R., Perera W. R., Sapsford R. J., Wedzicha J. A., Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations American Journal of Respiratory and Critical Care Medicine 2008 178 11 1139 1147
32. Rubin B. K., Henke M. O., Immunomodulatory activity and effectiveness of macrolides in chronic airway disease Chest 2004 125 2 70S 78S (Pubitemid 38200963)
33. Nakanishi Y., Kobayashi D., Asano Y., Sakurai T., Kashimura M., Okuyama S., Yoneda Y., Shapiro S. D., Takayama K., Clarithromycin prevents smoke-induced emphysema in mice American Journal of Respiratory and Critical Care Medicine 2009 179 4 271 278
34. Stefanska A. M., Walsh P. T., Chronic obstructive pulmonary disease: evidence for an autoimmune component Cellular and Molecular Immunology 2009 6 2 81 86
35. Ishida Y., Abe Y., Harabuchi Y., Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes International Journal of Pediatric Otorhinolaryngology 2007 71 2 297 305 (Pubitemid 46054178)
36. Ito T., Ito N., Hashizume H., Takigawa M., Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells Journal of Dermatological Science 2009 54 3 185 191
37. Yasutomi M., Ohshima Y., Omata N., Yamada A., Iwasaki H., Urasaki Y., Mayumi M., Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells The Journal of Immunology 2005 175 12 8069 8076 (Pubitemid 41798369)